메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background and Objectives:Diabetes mellitus (DM) is a risk factor for sudden sensorineural hearing loss (SSNHL), possiblydue to microvascular damage as well as increased blood viscosity and embolic and thrombotic episodes. To perform a prospective,randomized clinical trial to evaluate the therapeutic effect of lipo-prostaglandin E1 (lipo-PGE1) on SSNHL in Korean patientswith type 2 diabetes. Materials and Method:The study group consisted of 270 patients (130 males, 140 females) consecutivelydiagnosed with SSNHL. Patients were classified as diabetic or nondiabetic by the new American Diabetes Association criteria. Withthe approval of the institute ethics committee, patients were randomly assigned to treatment with a continuous infusion of 10 Llipo-PGE1 (lipo-PGE1 group) or saline (placebo group). In addition, all patients studied were treated with 48 mg methylprednisolonefor 5 days. Results:The overall recovery rates after treatment were 51.5% in diabetic and 64.2% in nondiabetic patients. Indiabetic patients, there was a significantly higher rate of hearing improvement in the lipo-PGE1 group (64.7%) than in the placebogroup (37.5%), whereas, in nondiabetic patients, there was no significant difference in the rate of hearing improvement betweenthe lipo-PGE1 group (70.3%) and the placebo group (58.3%). Conclusion:Lipo-PGE1 may have beneficial effects in the treatmentof SSNHL in Korean patients with type 2 diabetes. (Korean J Otolaryngol 2006;49:973-7)

목차

등록된 정보가 없습니다.

참고문헌 (18)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0